Editorial: Common pathogenic mechanism of cerebrovascular disease and degenerative diseases.

Wei Zheng,Yuqing Liang,Dongsheng Fan,Ji He

DOI: https://doi.org/10.3389/fnins.2023.1233204

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 23 June 2023Sec. Neurodegeneration Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1233204

What problem does this paper attempt to address?

Editorial: Common Pathogenic Mechanism of Cerebrovascular Disease and Degenerative Diseases

Wei Zheng,Yuqing Liang,Dongsheng Fan,Ji He

DOI: https://doi.org/10.3389/fnins.2023.1233204

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:COPYRIGHT © 2023 Zheng, Liang, Fan and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Common pathogenic mechanism of cerebrovascular disease and degenerative diseases
Editorial: Understanding the Heterogeneity and Spatial Brain Environment of Neurodegenerative Diseases Through Conventional and Future Methods

Cui Li,Marissa L Dubbelaar,Xiaoming Zhang,Jialin C Zheng

DOI: https://doi.org/10.3389/fncel.2023.1211273

2023-01-01

Frontiers in Cellular Neuroscience

Abstract:COPYRIGHT © 2023 Li, Dubbelaar, Zhang and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Understanding the heterogeneity and spatial brain environment of neurodegenerative diseases through conventional and future methods
Editorial: Targeting Neuron-Non-neuronal Interactions at the Neurovascular Unit in Stroke and Neurodegenerative Disease Models

Changxiang Li,Yang Liu,Jian Liu,Xiaoyu Xu

DOI: https://doi.org/10.3389/fncel.2024.1353281

2024-01-01

Frontiers in Cellular Neuroscience

Abstract:EDITORIAL article Front. Cell. Neurosci., 26 January 2024Sec. Cellular Neuropathology Volume 18 - 2024 | https://doi.org/10.3389/fncel.2024.1353281
Editorial: Mitochondrial and Lysosomal Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Strategies

Xiang Chen,Xiao Yousheng,Xiaolei Zhu,Wenjie Yang,Pu Jiali,Pei Zhong

DOI: https://doi.org/10.3389/fnagi.2022.1029440

IF: 4.8

2022-01-01

Frontiers in Aging Neuroscience

Abstract:EDITORIAL article Front. Aging Neurosci., 04 October 2022Sec. Cellular and Molecular Mechanisms of Brain-aging Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.1029440
Editorial: Application of Gene Editing in Pathology Dissection of Neurodegenerative Diseases.

Sen Yan,Xingshun Xu,Fangfang Qi,Xing Guo,Junhong Luo,Yujing Li

DOI: https://doi.org/10.3389/fnins.2022.1092176

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 05 January 2023Sec. Neurodegeneration Volume 16 - 2022 | https://doi.org/10.3389/fnins.2022.1092176
Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases

Yang-Wei Cai,Mao-Xiong Wu,Qing-Yuan Gao,Jing-Feng Wang,Yu-Li Huang,Yun-Zhao Hu,Ruo-Feng Qiu,Wei-Yi Mai,Hai-Feng Zhang

DOI: https://doi.org/10.3389/fcvm.2023.1270320

IF: 3.6

2023-01-01

Frontiers in Cardiovascular Medicine

Abstract:EDITORIAL article Front. Cardiovasc. Med., 24 August 2023Sec. Cardiovascular Genetics and Systems Medicine Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1270320
Editorial: Cerebral autoregulation and neurovascular coupling in brain disorders

Xiuyun Liu,Marek Czosnyka,Chiara Robba,Dong Ming

DOI: https://doi.org/10.3389/fneur.2022.1001342

IF: 3.4

2022-01-01

Frontiers in Neurology

Abstract:EDITORIAL article Front. Neurol., 09 September 2022Sec. Neurocritical and Neurohospitalist Care https://doi.org/10.3389/fneur.2022.1001342
Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis

Yingchao Shi,Wenhao Liu,Yang Yang,Yali Ci,Lei Shi

DOI: https://doi.org/10.3390/ijms24054839

IF: 5.6

2023-03-03

International Journal of Molecular Sciences

Abstract:The COVID-19 pandemic has caused millions of deaths and remains a major public health burden worldwide. Previous studies found that a large number of COVID-19 patients and survivors developed neurological symptoms and might be at high risk of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). We aimed to explore the shared pathways between COVID-19, AD, and PD by using bioinformatic analysis to reveal potential mechanisms, which may explain the neurological symptoms and degeneration of brain that occur in COVID-19 patients, and to provide early intervention. In this study, gene expression datasets of the frontal cortex were employed to detect common differentially expressed genes (DEGs) of COVID-19, AD, and PD. A total of 52 common DEGs were then examined using functional annotation, protein–protein interaction (PPI) construction, candidate drug identification, and regulatory network analysis. We found that the involvement of the synaptic vesicle cycle and down-regulation of synapses were shared by these three diseases, suggesting that synaptic dysfunction might contribute to the onset and progress of neurodegenerative diseases caused by COVID-19. Five hub genes and one key module were obtained from the PPI network. Moreover, 5 drugs and 42 transcription factors (TFs) were also identified on the datasets. In conclusion, the results of our study provide new insights and directions for follow-up studies of the relationship between COVID-19 and neurodegenerative diseases. The hub genes and potential drugs we identified may provide promising treatment strategies to prevent COVID-19 patients from developing these disorders.

biochemistry & molecular biology,chemistry, multidisciplinary
Editorial: the Role of Neurovascular Unit in Neurodegeneration

Zhi Dong Zhou,Dennis Qing Wang,Eng-King Tan

DOI: https://doi.org/10.3389/fncel.2022.870631

2022-01-01

Frontiers in Cellular Neuroscience

Abstract:with a signiﬁcant decrease of stimulus-induced CBF responses. Their ﬁndings conﬁrm the vital role of pericytes in modulating the NVC process, which suggests that they may play a part in neurological conditions associated with acute or chronic pericyte depletion (such as hypoperfusion and stroke, as well as human neurodegenerative conditions such as AD).
Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Feng Han

DOI: https://doi.org/10.1136/svn-2018-000213

IF: 5.9

2019-01-01

Stroke and Vascular Neurology

Abstract:Maintaining normal learning and memory functions requires a high degree of coordination between neural and vascular cells. Basic and clinical studies have shown that brain microvasculature dysfunction activates inflammatory cells in the brain, leading to progressive neuronal loss and eventually dementia. This review focuses on recent studies aimed at identifying the molecular events that link cerebral microvascular dysfunction to neurodegeneration, including oxidative/nitrosative stress, cellular metabolic dysfunction, inflammatory signalling and abnormal synaptic plasticity. A better understanding of the coupling between vasculature and brain neurons and how this coupling is disrupted under pathological conditions is of great significance in identifying new diagnostic and treatment targets for dementia for which no new drugs have been approved since 2003.
Editorial: Application of gene editing in neurodegenerative diseases, volume II

Fangfang Qi,Xingshun Xu,Xing Guo,Junhong Luo,Yujing Li,Sen Yan

DOI: https://doi.org/10.3389/fnins.2023.1305302

IF: 4.3

2023-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 31 October 2023Sec. Neurodegeneration Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1305302
Editorial: Immune Mechanisms in white matter lesions: Clinical and pathophysiological implications

Xiao-Wei Pang,Cui Mei,Wei Qiu,Long-Jun Wu,Dai-Shi Tian

DOI: https://doi.org/10.3389/fimmu.2023.1149625

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:EDITORIAL article Front. Immunol., 31 January 2023Sec. Multiple Sclerosis and Neuroimmunology Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1149625
Editorial: the Alzheimer's Disease Challenge

Athanasios Alexiou,Mohammad A. Kamal,Ghulam Md Ashraf

DOI: https://doi.org/10.3389/fnins.2019.00768

IF: 4.3

2019-01-01

Frontiers in Neuroscience

Abstract:EDITORIAL article Front. Neurosci., 10 January 2023Sec. Neurodegeneration Volume 16 - 2022 | https://doi.org/10.3389/fnins.2022.1127189
Editorial: Nutritional interventions on age-related neurodegenerative diseases

Tiantian Zhang,Zhigang Liu,Yashi Mi

DOI: https://doi.org/10.3389/fnagi.2023.1215586

IF: 4.8

2023-01-01

Frontiers in Aging Neuroscience

Abstract:EDITORIAL article Front. Aging Neurosci., 13 June 2023Sec. Neurocognitive Aging and Behavior Volume 15 - 2023 | https://doi.org/10.3389/fnagi.2023.1215586
Editorial: Using novel technologies and models to identify biomarkers and explore therapeutic strategies for neurological disorders.

Liwei Xing,Chengbiao Wu,Jiaojian Wang,Sheng Wei,Kai Yuan,Dongdong Qin

DOI: https://doi.org/10.3389/fnbeh.2023.1151667

IF: 3.617

2023-01-01

Frontiers in Behavioral Neuroscience

Abstract:EDITORIAL article Front. Behav. Neurosci., 23 March 2023Sec. Pathological Conditions Volume 17 - 2023 | https://doi.org/10.3389/fnbeh.2023.1151667
Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

Tongli Chen,Yan Dai,Chenghao Hu,Zihao Lin,Shengzhe Wang,Jing Yang,Linghui Zeng,Shanshan Li,Weiyun Li

DOI: https://doi.org/10.1186/s12987-024-00557-1

2024-07-20

Fluids and Barriers of the CNS

Abstract:Maintaining the structural and functional integrity of the blood–brain barrier (BBB) is vital for neuronal equilibrium and optimal brain function. Disruptions to BBB performance are implicated in the pathology of neurodegenerative diseases.

neurosciences
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease.

Yuhai Zhao,Walter J Lukiw

DOI: https://doi.org/10.3389/fncel.2022.937961

2022-01-01

Frontiers in Cellular Neuroscience

Abstract:OPINION article Front. Cell. Neurosci., 17 June 2022Sec. Cellular Neuropathology https://doi.org/10.3389/fncel.2022.937961
Endothelial Dysfunction in Neurodegenerative Diseases

Yao-Ching Fang,Yi-Chen Hsieh,Chaur-Jong Hu,Yong-Kwang Tu

DOI: https://doi.org/10.3390/ijms24032909

2023-02-02

Abstract:The cerebral vascular system stringently regulates cerebral blood flow (CBF). The components of the blood-brain barrier (BBB) protect the brain from pathogenic infections and harmful substances, efflux waste, and exchange substances; however, diseases develop in cases of blood vessel injuries and BBB dysregulation. Vascular pathology is concurrent with the mechanisms underlying aging, Alzheimer's disease (AD), and vascular dementia (VaD), which suggests its involvement in these mechanisms. Therefore, in the present study, we reviewed the role of vascular dysfunction in aging and neurodegenerative diseases, particularly AD and VaD. During the development of the aforementioned diseases, changes occur in the cerebral blood vessel morphology and local cells, which, in turn, alter CBF, fluid dynamics, and vascular integrity. Chronic vascular inflammation and blood vessel dysregulation further exacerbate vascular dysfunction. Multitudinous pathogenic processes affect the cerebrovascular system, whose dysfunction causes cognitive impairment. Knowledge regarding the pathophysiology of vascular dysfunction in neurodegenerative diseases and the underlying molecular mechanisms may lead to the discovery of clinically relevant vascular biomarkers, which may facilitate vascular imaging for disease prevention and treatment.
Editorial overview: Introduction to neurobiology of disease

Erik S Musiek,Eric J Nestler,Erik S. Musiek,Eric J. Nestler

DOI: https://doi.org/10.1016/j.conb.2024.102875

IF: 7.07

2024-04-14

Current Opinion in Neurobiology

Abstract:Neurodegenerative disorders encompass a wide range of syndromes that share key features. By their very name, all involve the death of specific neuronal cell types in different parts of the brain. All arise relatively late in life, often with advanced age, and are increasing in prevalence secondary to the world's aging population. Importantly, all neurodegenerative disorders have known genetic underpinnings. Some neurodegenerative conditions, such as Huntington disease and spinal muscular

neurosciences
Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants

Kyonghwan Choe,Hyun Young Park,Muhammad Ikram,Hyeon Jin Lee,Tae Ju Park,Rahat Ullah,Myeong Ok Kim

DOI: https://doi.org/10.3390/cells11081298

IF: 6

2022-04-11

Cells

Abstract:The novel coronavirus (2019-nCoVCOVID-19) belongs to the Beta coronavirus family, which contains MERS-CoV (Middle East respiratory syndrome coronavirus) and SARS-CoV (severe acute respiratory syndrome coronavirus). SARS-CoV-2 activates the innate immune system, thereby activating the inflammatory mechanism, causing the release of inflammatory cytokines. Moreover, it has been suggested that COVID-19 may penetrate the central nervous system, and release inflammatory cytokines in the brains, inducing neuroinflammation and neurodegeneration. Several links connect COVID-19 with Alzheimer’s disease (AD), such as elevated oxidative stress, uncontrolled release of the inflammatory cytokines, and mitochondrial apoptosis. There are severe concerns that excessive immune cell activation in COVID-19 may aggravate the neurodegeneration and amyloid-beta pathology of AD. Here, we have collected the evidence, showing the links between the two diseases. The focus has been made to collect the information on the activation of the inflammation, its contributors, and shared therapeutic targets. Furthermore, we have given future perspectives, research gaps, and overlapping pathological bases of the two diseases. Lastly, we have given the short touch to the drugs that have equally shown rescuing effects against both diseases. Although there is limited information available regarding the exact links between COVID-19 and neuroinflammation, we have insight into the pathological contributors of the diseases. Based on the shared pathological features and therapeutic targets, we hypothesize that the activation of the immune system may induce neurological disorders by triggering oxidative stress and neuroinflammation.

cell biology

Editorial: Common pathogenic mechanism of cerebrovascular disease and degenerative diseases.

Editorial: Common Pathogenic Mechanism of Cerebrovascular Disease and Degenerative Diseases

Editorial: Understanding the Heterogeneity and Spatial Brain Environment of Neurodegenerative Diseases Through Conventional and Future Methods

Editorial: Targeting Neuron-Non-neuronal Interactions at the Neurovascular Unit in Stroke and Neurodegenerative Disease Models

Editorial: Mitochondrial and Lysosomal Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Strategies

Editorial: Application of Gene Editing in Pathology Dissection of Neurodegenerative Diseases.

Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases

Editorial: Cerebral autoregulation and neurovascular coupling in brain disorders

Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis

Editorial: the Role of Neurovascular Unit in Neurodegeneration

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Editorial: Application of gene editing in neurodegenerative diseases, volume II

Editorial: Immune Mechanisms in white matter lesions: Clinical and pathophysiological implications

Editorial: the Alzheimer's Disease Challenge

Editorial: Nutritional interventions on age-related neurodegenerative diseases

Editorial: Using novel technologies and models to identify biomarkers and explore therapeutic strategies for neurological disorders.

Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease.

Endothelial Dysfunction in Neurodegenerative Diseases

Editorial overview: Introduction to neurobiology of disease

Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants